We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With Ambrisentan

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01051960
Recruitment Status : Completed
First Posted : January 20, 2010
Last Update Posted : March 7, 2018
Gilead Sciences
Information provided by (Responsible Party):
Rajan Saggar, University of California, Los Angeles

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : June 2010
  Study Completion Date : January 2011